Immediate Impact
58 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Works of Sara Nunnery being referenced
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
2020
Management of toxicity to isoform α-specific PI3K inhibitors
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sara Nunnery | 110 | 148 | 80 | 14 | 326 | |
| Mellett Lb | 129 | 111 | 46 | 13 | 311 | |
| Chatchawin Assanasen | 60 | 123 | 68 | 16 | 338 | |
| Frank Richard | 51 | 113 | 104 | 17 | 363 | |
| Michelle Purdom | 129 | 106 | 74 | 13 | 289 | |
| Wasserman Th | 101 | 73 | 106 | 10 | 344 | |
| RM Schmid | 114 | 138 | 78 | 16 | 356 | |
| Katerina Sfiridaki | 92 | 107 | 144 | 17 | 371 | |
| Comis Rl | 189 | 154 | 60 | 11 | 339 | |
| Albert Clarysse | 91 | 81 | 95 | 16 | 306 | |
| Su‐Chen Lee | 94 | 207 | 30 | 20 | 367 |
All Works
Login with ORCID to disown or claim papers
Loading papers...